氯己定脂质纳米粒加入生物陶瓷根管封闭剂的体外研究
本研究评估载氯己定脂质体与BioRoot RCS(BR)联合后的药物释放、抗菌活性及理化性能。脂质体氯己定使BR释放量最高提高7倍,并能完全抑制人牙本质上的粪肠球菌生物膜,但细胞毒性升高但仍高于ISO阈值。该制剂在不显著改变BR理化性能的前提下增强抗菌效果。
要点
- 脂质体氯己定使BR的CHX释放量最高提高7倍,呈三相释放模式。
- BR联合脂质体氯己定可完全抑制人牙本质上的粪肠球菌生物膜。
- 脂质体氯己定降低BR接触角和溶解度,细胞毒性升高但仍高于ISO阈值。
核心结论
- 脂质体氯己定制剂改善BR中CHX释放,增强抗菌效果且不显著改变BR理化性能。
研究设计与样本
- 体外研究,评估载氯己定脂质体与BioRoot RCS联合的药物释放、抗菌、细胞毒性及理化性能。
主要发现
- 脂质体氯己定从BR释放的CHX量比CHX溶液最高高7倍(P < .05),呈三相释放模式。
- BR联合选定脂质体氯己定完全抑制人牙本质上粪肠球菌生物膜生长(P < .05)。
- 脂质体氯己定降低BR接触角(P < .05)和溶解度,但增加细胞毒性(P < .05)且仍高于ISO阈值。
- 其他理化性能与BR无差异(P > .05)。
关键数值与推荐
- 药物释放评估30天,采用分光光度法和数学模型。
- 抗菌评估采用人牙本质上粪肠球菌生物膜。
- 细胞毒性按ISO 10993-5:2019标准在第1、3、7天评估。
- 理化性能评估包括凝固时间、傅里叶变换红外光谱、溶解度、接触角和膜厚度。
临床怎么用
- 该脂质体氯己定-BR组合有望用于牙髓局部抗生物膜治疗,且不显著改变BR理化性能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: This study aimed to assess BioRoot RCS (BR) incorporating liposomal chlorhexidine digluconate (CHX) for its antibacterial activity, drug release capacity, and physicochemical properties. METHODS: Drug release of CHX liposomal formulations in combination with BR was evaluated spectrophotometrically and through mathematical release models for 30 days. A selected combination was evaluated for antimicrobial properties against Enterococcus faecalis biofilm growth on human dentin. Cytotoxicity was assessed following the ISO 10993-5:2019 standard on days 1, 3, and 7. Physicochemical properties were evaluated through setting time, Fourier transform infrared spectroscopy, solubility, contact angle, and film thickness. RESULTS: From BR, liposomal CHX released up to 7-fold higher CHX than CHX solution (P < .05), following a triphasic drug release pattern compared to the CHX solution, which followed a quasi-Fickian diffusion. BR combined with a selected liposomal CHX completely inhibited E. faecalis biofilm growth compared to the combination of BR with CHX solution and the control group (P < .05). Liposomal CHX decreased the contact angle (P < .05) and solubility but increased cytotoxicity (P < .05) of BR, staying above the ISO threshold. None of the other physicochemical characteristics tested differed from BR (P > .05). CONCLUSION: This liposomal formulation improved CHX release from BR, enhancing the antibacterial effectiveness. It presents a promising approach for local antibiofilm therapy in endodontics without substantially altering the physicochemical characteristics of BR.
引用
- Raddi S, El Karmy B, Martinache O, et al. Development of Chlorhexidine-loaded Lipid Nanoparticles Incorporated in a Bioceramic Endodontic Sealer. J Endod. 2024. PMID: 38710385. doi:10.1016/j.joen.2024.04.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。